Saturday 17 October 2026
Export IMCC’s income statement to Excel — free account
IM Cannabis Corp.
IMCC Healthcare Drug Manufacturers Specialty & Generic
IM Cannabis Corp.’s revenue for fiscal 2025 (year ended December 2025) was $39.2 million, down 0.66% from fiscal 2024. In the quarter to June 2026, revenue fell 40.3%, EPS fell 385.7%, free cash flow fell 266.8% and total debt fell 64.7%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
1.36
0.03
+2.26%
Follow IMCC
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
3 | 4 | 5 | 6 |
+8 more TTM periods Free account |
| 2,280.06% | 1,305.05% | 5,562.03% | (107.89%) | ||
| (54.20%) | (40.98%) | (31.58%) | (10.32%) | ||
ROIC |
0.00% | 0.00% | 0.00% | (86.01%) | |
Return on Tangible Assets |
189.48% | 152.29% | 149.84% | 155.22% | |
Average Days of Receivables |
54.63 | 51.83 | 72.35 | 79.58 | |
Free Cash Flow per Share |
(1.58) | 0.60 | 24.18 | (16.85) | |
Free Cash Flow |
(0.49) | 0.12 | 3.41 | (2.73) | |
Capital Expenditures |
(0.01) | (0.01) | 0.04 | (0.01) | |
| Other line items | |||||
Cash ROIC |
20.88% | (6.41%) | 381.04% | (45.34%) | |
Accounts Receivable Turnover |
4.73 | 4.37 | 4.39 | 3.45 | |
Accounts Payable Turnover |
3.88 | 3.64 | 3.84 | 3.31 | |
Inventory Turnover |
12.29 | 11.91 | 11.94 | 5.50 | |
Average Days of Payables |
77.24 | 69.90 | 97.68 | 66.00 | |
Days of Inventory on Hand |
26.05 | 17.05 | 34.58 | 92.56 | |
Tax Rate |
0.00 | 0.01 | 0.01 | 0.01 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
31.69% | 28.86% | 27.20% | 26.36% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.03% | 1.51% | |
Interest Coverage |
(2.76) | (3.10) | (3.31) | (1.04) | |
Operating CF/Net income |
0.04 | (0.01) | (0.42) | 0.81 | |
Depreciation/Fixed assets |
0.47 | 0.45 | 0.44 | 0.44 | |
Capex/Depreciation |
(0.01) | (0.01) | 0.03 | (0.01) | |
Revenue per Share |
107.24 | 186.38 | 277.41 | 231.32 | |
Operating CF per Share |
(1.54) | 0.67 | 23.90 | (16.78) | |
Capex per Share |
(0.03) | (0.07) | 0.28 | (0.07) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates